BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23749933)

  • 1. Different impact of IL10 haplotype on prognosis in lung squamous cell carcinoma and adenocarcinoma.
    Wang YC; Sung WW; Wang L; Cheng YW; Chen CY; Wu TC; Shieh SH; Lee H
    Anticancer Res; 2013 Jun; 33(6):2729-35. PubMed ID: 23749933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 haplotype may predict survival and relapse in resected non-small cell lung cancer.
    Wang YC; Sung WW; Wu TC; Wang L; Chien WP; Cheng YW; Chen CY; Shieh SH; Lee H
    PLoS One; 2012; 7(7):e39525. PubMed ID: 22848356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
    Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
    Behrens C; Solis LM; Lin H; Yuan P; Tang X; Kadara H; Riquelme E; Galindo H; Moran CA; Kalhor N; Swisher SG; Simon GR; Stewart DJ; Lee JJ; Wistuba II
    Clin Cancer Res; 2013 Dec; 19(23):6556-65. PubMed ID: 24097870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
    Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Kim HT; Lee JE; Shin ES; Yoo YK; Cho JH; Yun MH; Kim YH; Kim SK; Kim HJ; Jang TW; Kwak SM; Kim CS; Ryu JS
    J Clin Oncol; 2008 Dec; 26(36):5972-9. PubMed ID: 19018088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
    Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
    J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
    Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
    Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
    J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
    Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
    BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
    Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
    J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.
    Uzunoglu FG; Yavari N; Bohn BA; Nentwich MF; Reeh M; Pantel K; Perez D; Tsui TY; Bockhorn M; Mann O; Izbicki JR; Wikman H; Vashist YK
    Lung Cancer; 2013 Jul; 81(1):123-9. PubMed ID: 23548249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
    Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
    BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer.
    Zhang Y; Wang H; Wang J; Bao L; Wang L; Huo J; Wang X
    Cancer Metastasis Rev; 2015 Jun; 34(2):249-64. PubMed ID: 25937073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.